Upregulation of miR-223 in the rat liver inhibits proliferation of hepatocytes under simulated microgravity.
- Author:
Yongjie CHEN
1
;
Ji XU
;
Chao YANG
;
Hongyu ZHANG
;
Feng WU
;
Jian CHEN
;
Kai LI
;
Hailong WANG
;
Yu LI
;
Yinghui LI
;
Zhongquan DAI
Author Information
- Publication Type:Original Article
- MeSH: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Biomarkers; Blotting, Western; Cell Cycle; Cell Cycle Checkpoints; Cell Proliferation; Cyclin D3; Hepatocytes*; Hindlimb Suspension; In Vitro Techniques; Liver*; Proliferating Cell Nuclear Antigen; Rats*; Real-Time Polymerase Chain Reaction; Space Flight; Up-Regulation*; Weightlessness*
- From:Experimental & Molecular Medicine 2017;49(6):e348-
- CountryRepublic of Korea
- Language:English
- Abstract: Long-term spaceflight affects numerous organ systems in the body, including metabolic dysfunction. Recently, ample evidence has demonstrated that the liver is a vulnerable organ during spaceflight. However, the changes in hepatocyte proliferation and cell cycle control under microgravity remain largely unexplored. In the present study, we first confirmed that the serum levels of aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase, biochemical markers of liver function, were altered in rats under tail suspension (TS) conditions to simulate microgravity, as shown in previous reports. Next, we demonstrated that the cell proliferation activity, determined by Ki67, PCNA and PH3, was significantly decreased at the different TS time points (TS for 14, 28 and 42 days) compared with that in the control group. Consistently, the positive cell cycle regulators Ccna2, Ccnd1, Cdk1, Cdk2 and cyclin D3 were also significantly decreased in the TS groups as shown by quantitative real-time PCR and western blotting analysis. Subsequent analysis revealed that the aberrant hepatocyte proliferation inhibition under simulated microgravity was associated with the upregulation of miR-223 in the liver. We further found that miR-223 inhibited the proliferation of Hepa1-6 cells and identified CDK2 and CUL1 as its direct targets. In addition, the decreased expression of CDK2 and CUL1 was negatively correlated with the level of p27 in vitro and in vivo, which may have been responsible for retarding hepatocyte proliferation. Collectively, these data indicate that upregulation of miR-223 was associated with the inhibition of liver cell growth and reveal the role of miR-223 in rat hepatocyte proliferation disorders and the pathophysiological process under simulated microgravity.
